Recombinant growth hormone therapy for X‐linked hypophosphatemia in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Growth Hormone Therapy for X‐linked Hypophosphatemia in Children." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432252/all/Recombinant_growth_hormone_therapy_for_X‐linked_hypophosphatemia_in_children. Accessed 30 September 2023.
Recombinant growth hormone therapy for X‐linked hypophosphatemia in children. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432252/all/Recombinant_growth_hormone_therapy_for_X‐linked_hypophosphatemia_in_children. Accessed September 30, 2023.
Recombinant growth hormone therapy for X‐linked hypophosphatemia in children. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432252/all/Recombinant_growth_hormone_therapy_for_X‐linked_hypophosphatemia_in_children
Recombinant Growth Hormone Therapy for X‐linked Hypophosphatemia in Children [Internet]. In: Cochrane Abstracts. [cited 2023 September 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432252/all/Recombinant_growth_hormone_therapy_for_X‐linked_hypophosphatemia_in_children.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant growth hormone therapy for X‐linked hypophosphatemia in children
ID - 432252
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432252/all/Recombinant_growth_hormone_therapy_for_X‐linked_hypophosphatemia_in_children
DB - Evidence Central
DP - Unbound Medicine
ER -